Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actelion Pharmaceuticals LtdfiledCriticalActelion Pharmaceuticals Ltd
Publication of AR109745A2publicationCriticalpatent/AR109745A2/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Compuesto caracterizado porque tiene fórmula estructural (1) o las sales del mismo. Dicho compuesto es útil como antagonista del receptor endotelina. Se relaciona además con la preparación de dicho compuesto.Compound characterized in that it has structural formula (1) or salts thereof. Said compound is useful as an endothelin receptor antagonist. It is also related to the preparation of said compound.
ARP170102694A2007-08-172017-09-28
DERIVATIVE OF 4-PYRIMIDINSULFAMIDE
AR109745A2
(en)
Compounds derived from substituted piperidine; Preparation process; Pharmaceutical composition and its use to produce an antiproliferative and / or proapoptotic effect.